Two biotechs are braving the roiling financial markets to raise money for clinical trials. AN2 Therapeutics is preparing for a pivotal test of its boron-based drug candidate for a rare, chronic lung disease. Okyo Pharma also filed IPO paperwork as it looks to advance to the clinic with its dry eye disease drug.
Also, Biogen and University of Pennsylvania embark on gene therapy alliance and Mark Cuban said he was asked to run for president (and said no).
There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.
Efforts to rein in rapidly rising healthcare costs will require new team-based payment and delivery approaches, which would demand sacrifices from hospitals, doctors and insurers, according to the Boston Globe.
UnitedHealth Group Inc., one of the nation's largest health insurers, predicts that a majority of Americans could have diabetes or pre-diabetes by 2020, at a cost of $3.35 trillion to the health care system over the next 10 years, reports the Minneapolis/St. Paul Business Journal.